Latest Updates & News

FDA Approves NEXLETOL for High Cholesterol Management on March 22, 2024

FDA Approves NEXLETOL for High Cholesterol Management on March 22, 2024

What is NEXLETOL prescribed for?   Nexletol is approved to help decrease LDL cholesterol in adults with heart disease or heterozygous familial hypercholesterolemia (HeFH). What is the name of the drug and what does it do? NEXLETOL, pronounced NEX-le-tol, (generic name: bempedoic acid) is a prescription medicine originally used to help reduce the risk of...

Exciting New Drug Approval: WINREVAIR: March 26, 2024

Exciting New Drug Approval: WINREVAIR: March 26, 2024

What is WINREVAIR prescribed for?  WINREVAIR is prescribed to treat adults with pulmonary arterial hypertension. What is the name of the drug and what does it do? WINREVAIR pronounced WIN-reh-vair, (generic name: sotatercept-csrk) is used to treat adults with pulmonary arterial hypertension (PAH), a condition where there is high blood pressure in the arteries...

New Use for Wegovy Approved by FDA to Reduce Cardiovascular Risk:  March 08, 2024

New Use for Wegovy Approved by FDA to Reduce Cardiovascular Risk:  March 08, 2024

What is Wegovy prescribed for?   Wegovy (generic name: semaglutide), pronounced “weh-Go-veeh,” is an injectable prescription medication for adults with obesity (BMI ≥30) or overweight (excess weight) (BMI ≥27) who also have weight-related medical problems, to help them lose weight and keep it off. What is the name of the drug and what does it do?  The...

New Blood Test for Colon Cancer Recommended for Approval: May 24, 2024

New Blood Test for Colon Cancer Recommended for Approval: May 24, 2024

What is it prescribed for?   The Guardant Health Shield test is a blood test that screens for colorectal cancer (CRC) in people who are 45 and older and at average risk of the disease.  The test looks for DNA fragments from tumor cells and precancerous growths in blood samples collected with a Guardant Blood Collection Kit. What is the name of the drug and what...